Xlife Sciences AG: New project in the portfolio
We are pleased to announce that Xlife Sciences AG has added saniva diagnostics GmbH to the portfolio.
saniva diagnostics GmbH
Detecting diseases at an early stage is crucial to modern medical science. The timing of a diagnosis can significantly impact the chances of healing and the effectiveness of therapy. saniva diagnostics GmbH, a spin-off of the University Hospital Jena is developing a screening instrument to detect neurodegenerative diseases such as Parkinson or dementia at a very early stage. This screening instrument works by analyzing human movement.
Xlife Sciences AG
End of Media Release
Issuer: Xlife Sciences AG
Key word(s): Finance
04.11.2019 Dissemination of a Press Release, transmitted by DGAP - a service of EQS Group AG.
|Company:||Xlife Sciences AG|
|Phone:||0041 44 385 84 60|
|Listed:||Regulated Unofficial Market in Munich|
|EQS News ID:||902715|
|End of News||DGAP Media|